sendolor 1 mg/ml injektionsvätska, lösning
eurocept international b.v. - morfinhydroklorid (trihydrat) - injektionsvätska, lösning - 1 mg/ml - morfinhydroklorid (trihydrat) 1 mg aktiv substans
sendolor 20 mg/ml injektionsvätska, lösning
eurocept international b.v. - morfinhydroklorid (trihydrat) - injektionsvätska, lösning - 20 mg/ml - morfinhydroklorid (trihydrat) 20 mg aktiv substans
sinmelan 5 mg/ml injektionsvätska, lösning
eurocept international b.v. - esketaminhydroklorid - injektionsvätska, lösning - 5 mg/ml - esketaminhydroklorid 5,77 mg aktiv substans
sinmelan 25 mg/ml injektionsvätska, lösning
eurocept international b.v. - esketaminhydroklorid - injektionsvätska, lösning - 25 mg/ml - esketaminhydroklorid 28,85 mg aktiv substans
senozam 1 mg/ml infusionsvätska, lösning
eurocept international b.v. - midazolam - infusionsvätska, lösning - 1 mg/ml - midazolam 1 mg aktiv substans
senozam 5 mg/ml infusionsvätska, lösning
eurocept international b.v. - midazolam - infusionsvätska, lösning - 5 mg/ml - midazolam 5 mg aktiv substans
thiotepa riemser
esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiska medel - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
sendolor 10 mg/ml infusionsvätska, lösning
eurocept international b.v. - morfinhydroklorid (trihydrat) - infusionsvätska, lösning - 10 mg/ml - morfinhydroklorid (trihydrat) 10 mg aktiv substans
sendolor 20 mg/ml infusionsvätska, lösning
eurocept international b.v. - morfinhydroklorid (trihydrat) - infusionsvätska, lösning - 20 mg/ml - morfinhydroklorid (trihydrat) 20 mg aktiv substans
sendolor 10 mg/ml injektionsvätska, lösning
eurocept international b.v. - morfinhydroklorid (trihydrat) - injektionsvätska, lösning - 10 mg/ml - morfinhydroklorid (trihydrat) 10 mg aktiv substans